| Mrs Ariel Joy Weishaar, FNP | |
|
739 1st St N, Shelby, MT 59474-1813 | |
| (406) 460-0683 | |
| Not Available |
| Full Name | Mrs Ariel Joy Weishaar |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 739 1st St N, Shelby, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760064232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | NUR-APRN-LIC-175087 (Montana) | Primary |
| 363LF0000X | Nurse Practitioner - Family | NUR-APRN-LIC-175087 (Montana) | Secondary |
| Entity Name | Premier Care Pediatrics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215361761 PECOS PAC ID: 1254631450 Enrollment ID: O20151119001183 |
News Archive
Doctors can use ultrasonography (ultrasound) to evaluate and diagnose muscular trauma in professional athletes on-site, which helps them to determine whether or not a player's injuries are severe enough to take them out of the game, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
New technologies and methods are spurring a renaissance in the study of organogenesis. Organogenesis, essentially the process through which a group of cells becomes a functioning organ, has important connections to biological processes at the cellular and developmental levels, and its study offers great potential for medical treatments through tissue engineering approaches.
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
"China has overhauled parts of its intellectual property laws to allow its drug makers to make cheap copies of medicines still under patent protection in an initiative likely to unnerve foreign pharmaceutical companies," Reuters reports.
Metabolic fatty liver disease, known as non-alcoholic fatty liver disease, is one of the most common causes of liver disease in Western countries and covers a spectrum of disorders.
› Verified 6 days ago
| Entity Name | Logan Health - Shelby |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497742415 PECOS PAC ID: 6608285192 Enrollment ID: O20220624001997 |
News Archive
Doctors can use ultrasonography (ultrasound) to evaluate and diagnose muscular trauma in professional athletes on-site, which helps them to determine whether or not a player's injuries are severe enough to take them out of the game, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
New technologies and methods are spurring a renaissance in the study of organogenesis. Organogenesis, essentially the process through which a group of cells becomes a functioning organ, has important connections to biological processes at the cellular and developmental levels, and its study offers great potential for medical treatments through tissue engineering approaches.
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
"China has overhauled parts of its intellectual property laws to allow its drug makers to make cheap copies of medicines still under patent protection in an initiative likely to unnerve foreign pharmaceutical companies," Reuters reports.
Metabolic fatty liver disease, known as non-alcoholic fatty liver disease, is one of the most common causes of liver disease in Western countries and covers a spectrum of disorders.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ariel Joy Weishaar, FNP 739 1st St N, Shelby, MT 59474-1813 Ph: (406) 460-0683 | Mrs Ariel Joy Weishaar, FNP 739 1st St N, Shelby, MT 59474-1813 Ph: (406) 460-0683 |
News Archive
Doctors can use ultrasonography (ultrasound) to evaluate and diagnose muscular trauma in professional athletes on-site, which helps them to determine whether or not a player's injuries are severe enough to take them out of the game, according to a study to be presented at the ARRS 2010 Annual Meeting in San Diego, CA.
New technologies and methods are spurring a renaissance in the study of organogenesis. Organogenesis, essentially the process through which a group of cells becomes a functioning organ, has important connections to biological processes at the cellular and developmental levels, and its study offers great potential for medical treatments through tissue engineering approaches.
Oncotarget recently published "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas" which reported that based on previous studies, the authors assessed the anti-proliferative effect of simvastatin, a Rho GTPase interfering drug, in three OCCC cell lines: JHOC-5, OVMANA and TOV-21G, and one high-grade serous ovarian cancer cell line, Caov3. The authors used the Rho GTPase interfering drug CID-1067700 as a control.
"China has overhauled parts of its intellectual property laws to allow its drug makers to make cheap copies of medicines still under patent protection in an initiative likely to unnerve foreign pharmaceutical companies," Reuters reports.
Metabolic fatty liver disease, known as non-alcoholic fatty liver disease, is one of the most common causes of liver disease in Western countries and covers a spectrum of disorders.
› Verified 6 days ago
Dr. Todd E Gianarelli, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 670 Park Ave, Marias Healthcare Services Inc, Shelby, MT 59474 Phone: 406-434-3100 Fax: 406-434-3143 | |
Dr. George Angelo Biancarelli, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 670 Park Ave, Shelby, MT 59474 Phone: 406-434-3100 Fax: 406-434-3143 | |
Dr. Lance Lynn Stewart, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 670 Park Ave, Shelby, MT 59474 Phone: 406-434-3100 Fax: 406-434-3143 | |
Dr. Marc E Adams, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 670 Park Ave, Shelby, MT 59474 Phone: 406-434-3110 Fax: 406-434-3143 | |
Conley Lynch, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 670 Park Ave, Shelby, MT 59474 Phone: 406-434-3100 Fax: 406-434-3143 | |
Dr. Ronald Lee Burinsky, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 670 Park Ave, Shelby, MT 59474 Phone: 406-434-3100 Fax: 406-434-3143 | |
Dr. Robert A Clary, D.O. P C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Main St Ste C, Shelby, MT 59474 Phone: 406-424-8800 Fax: 406-424-8866 |